投稿日：2018/02/10(土) 19:00
投稿者：Natalie　[home]　[mail]

Sorry, you must have the wrong number mmc maxman iii The board is evaluating the company's oral drug,sapacitabine, which is being tested in a late-stage study inpatients with acute myeloid leukemia